TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Index Pharmaceuticals AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
8,787
|
0
|
11 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-7,906
|
-8,478
|
-9,345 |
| EBITDA |
-7,965
|
-8,747
|
-9,345 |
| Total assets |
24,677
|
27,236
|
33,401 |
| Current assets |
24,657
|
27,216
|
33,380 |
| Current liabilities |
24,147
|
23,326
|
19,928 |
| Equity capital |
529
|
3,909
|
13,469 |
| - share capital |
543
|
542
|
589 |
| Employees (average) |
5
|
6
|
6 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
2.1%
|
14.4%
|
40.3% |
| Turnover per employee |
1,757
|
0
|
2 |
| Profit as a percentage of turnover | -90.0% | -84954.5% | |
| Return on assets (ROA) |
-32.0%
|
-31.1%
|
-28.0% |
| Current ratio |
102.1%
|
116.7%
|
167.5% |
| Return on equity (ROE) |
-1494.5%
|
-216.9%
|
-69.4% |
| Change turnover |
8,787
|
-10
|
11 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-17%
|
0%
|
20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.